Overview
Mangrove Management Partners partners with vascular surgeons and interventionalists to improve patient outcomes while lowering costs in the healthcare system. The company focuses on vascular surgery and interventional procedures, offering best-in-class capabilities for healthcare management to support clinicians, payers, and patients. Its offering centers on investing in quality improvements and growth within the healthcare sector, aligning the interests of patients, providers, and investors to create a more efficient system. The revenue model comes from strategic investments in quality initiatives and sector growth, leveraging leadership expertise across healthcare, investment management, technology, and business development. By combining clinical partnerships with targeted investments and operational improvements, Mangrove aims to enhance outcomes, reduce costs, and drive sustainable growth in healthcare.
Work here?Claim your company
Simplify's Take
What believers are saying
- Mangrove backed CMS and MedPAC-friendly office-based care commentary in November 2025.
- Eight centers and fourteen offices signal continued footprint expansion.
- Paul Gagne's expanded research role strengthens outcomes branding and physician recruitment.
What critics are saying
- CMS reimbursement cuts can crush office-based vascular margins by 2027.
- Heavy New England concentration exposes Mangrove to local hospital-system competition.
- If physician partners defect, the affiliation model loses revenue and clinical control.
What makes Mangrove Management Partners unique
- Mangrove runs an integrated clinical, management, and research vascular platform.
- Eight full-service centers across fourteen offices deepen referral capture in New England.
- Proprietary data, EHR, and billing systems standardize care and improve efficiency.
Help us improve and share your feedback! Did you find this helpful?